Why the study?
Does incomplete revascularization increase the risk of mortality and MACE compared to complete revascularization in STEMI patients with multivessel disease across different age groups?
Does incomplete revascularization increase the risk of mortality and MACE compared to complete revascularization in STEMI patients with multivessel disease across different age groups?
Incomplete revascularization is associated with a higher risk of MACE in younger STEMI patients with multivessel disease, supporting routine complete revascularization in this group, but this benefit is not clearly seen in patients ≥75 years.
No takes yet. Share an insight, caveat, or question.
Incomplete revascularization may differentially affect morbi-mortality by age in STEMI with MVD; leaves open age-tailored strategies pending randomized confirmation.
Rúmiz et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: